Mapping the genes for arylamine N-acetyltransferases

Mapping the genes for arylamine N-acetyltransferases

<p>Arylamine N-acetyltransferases are xenobiotic metabolising enzymes, involved in metabolic pathways leading to either detoxification or bio-activation of drugs and carcinogens. In humans, polymorphisms of the two functional NAT genes (<em>NAT1</em> and <em>NAT2</em>}...

Descripció completa

Dades bibliogràfiques
Autor principal:	Fakis, G
Format:	Thesis
Publicat:	2000

Ítems similars

Expression of the genes for arylamine N-acetyltransferases in mice
per: Boukouvala, S, et al.
Publicat: (2002)

Structure and mechanism of arylamine N-acetyltransferases.
per: Westwood, I, et al.
Publicat: (2006)

Description of a novel polymorphic gene encoding for arylamine N-acetyltransferase in the rhesus macaque (Macaca mulatta), a model animal for endometriosis.
per: Fakis, G, et al.
Publicat: (2007)

Arylamine N-acetyltransferase in adult mouse brain
per: Mo, M, et al.
Publicat: (2004)

Structural Studies on the Mycobacterial Arylamine N-Acetyltransferases
per: Abuhammad, A, et al.
Publicat: (2010)

Arylamine N-acetyltransferase 2 gene polymorphism in an Algerian population
per: Hiba Chelouti, et al.
Publicat: (2017-08-01)

Chromosome mapping of the genes for murine arylamine N-acetyltransferases (NATs), enzymes involved in the metabolism of carcinogens: identification of a novel upstream noncoding exon for murine Nat2.
per: Fakis, G, et al.
Publicat: (2000)

Neuroendocrine expression of mouse arylamine N-acetyltransferase 2
per: Wakefield, L, et al.
Publicat: (2006)

Arylamine N-acetyltransferases: structural and functional implications of polymorphisms.
per: Sim, E, et al.
Publicat: (2008)

Humans and Chimpanzees Display Opposite Patterns of Diversity in Arylamine N-Acetyltransferase Genes
per: Christelle Vangenot, et al.
Publicat: (2019-07-01)

Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding
per: Laurieri, N, et al.
Publicat: (2014)

An approach to identifying novel substrates of bacterial arylamine N-acetyltransferases.
per: Brooke, E, et al.
Publicat: (2003)

Arylamine N-acetyltransferase expression during murine heart development
per: Wakefield, L, et al.
Publicat: (2004)

Biochemical Characterization of Arylamine N-acetyltransferases From Vibrio vulnificus
per: Xinning Liu, et al.
Publicat: (2021-01-01)

Structural investigation of mutant Mycobacterium smegmatis arylamine N-acetyltransferase: a model for a naturally occurring functional polymorphism in Mycobacterium tuberculosis arylamine N-acetyltransferase.
per: Kawamura, A, et al.
Publicat: (2003)

Selective small molecule inhibitors of the potential breast cancer marker, human arylamine N-acetyltransferase 1, and its murine homologue, mouse arylamine N-acetyltransferase 2.
per: Russell, A, et al.
Publicat: (2009)

Comparison of the Arylamine N-acetyltransferase from Mycobacterium marinum and Mycobacterium tuberculosis.
per: Fullam, E, et al.
Publicat: (2009)

Probing the architecture of the Mycobacterium marinum arylamine N-acetyltransferase active site.
per: Abuhammad, A, et al.
Publicat: (2010)

Protein-ligand interactions of arylamine N-acetyltransferase from Mycobacterium smegmatis
per: Brooke, E
Publicat: (2003)

Polymorphisms of arylamine N-acetyltransferase2 and risk of lung and colorectal cancer
per: Amjad Mahasneh, et al.
Publicat: (2012-01-01)

Arylamine N-Acetyltransferase 1 Activity is Regulated by the Protein Acetylation Status
per: Raúl A. Salazar-González, et al.
Publicat: (2022-01-01)

Over-expression, purification, and characterization of recombinant human arylamine N-acetyltransferase 1.
per: Wang, H, et al.
Publicat: (2005)

Eukaryotic arylamine N-acetyltransferase. Investigation of substrate specificity by high-throughput screening.
per: Kawamura, A, et al.
Publicat: (2005)

Identification of arylamine N-acetyltransferase inhibitors as an approach towards novel anti-tuberculars.
per: Westwood, I, et al.
Publicat: (2010)

Distribution of arylamine N-acetyltransferase 2 (NAT2) genotypes among Omanis
per: Musbah O. M. Tanira, et al.
Publicat: (2003-04-01)

Characterization of the putative operon containing arylamine N-acetyltransferase (nat) in Mycobacterium bovis BCG.
per: Anderton, M, et al.
Publicat: (2006)

Arylamine N-acetyltransferase 2 genotype-dependent N-acetylation of isoniazid in cryopreserved human hepatocytes
per: Mark A. Doll, et al.
Publicat: (2017-07-01)

Characterization of the putative operon containing arylamine N−acetyltransferase (nat) in Mycobacterium bovis BCG
per: Eltis, E
Publicat: (2006)

Inhibition of mycobacterial arylamine N-acetyltransferase contributes to anti-mycobacterial activity of Warburgia salutaris.
per: Madikane, V, et al.
Publicat: (2007)

Inhibition of mycobacterial arylamine N-acetyltransferase contributes to anti-mycobacterial activity of Warburgia salutaris
per: Madikane, V, et al.
Publicat: (2007)

Synthesis and in vitro evaluation of novel small molecule inhibitors of bacterial arylamine N-acetyltransferases (NATs).
per: Brooke, E, et al.
Publicat: (2003)

Novel small-molecule inhibitors of arylamine N-acetyltransferases: drug discovery by high-throughput screening.
per: Westwood, I, et al.
Publicat: (2011)

Arylamine N-Acetyltransferases from mycobacteria: investigations of a potential yarget for anti-tubercular therapy
per: Abuhammad, A
Publicat: (2013)

Hamster arylamine N-acetyltransferase 2: Investigation of substrate specificity by high-through-put screening
per: Kawamura, A, et al.
Publicat: (2004)

A pilot study of the modulation of sirtuins on arylamine N-acetyltransferase 1 and 2 enzymatic activity
per: Eneida Turiján-Espinoza, et al.
Publicat: (2018-03-01)

Association of the cytochrome P450 and arylamine N-acetyltransferase gene polymorphisms with the incidence of head and neck cancer in Polish population
per: Monika Gogolewska, et al.
Publicat: (2023-12-01)

Identification of new arylamine N-acetyltransferases and enhancing 2-acetamidophenol production in Pseudomonas chlororaphis HT66
per: Shuqi Guo, et al.
Publicat: (2020-05-01)

Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro.
per: Adam, P, et al.
Publicat: (2003)

The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis--an enzyme which inactivates the anti-tubercular drug, isoniazid.
per: Sandy, J, et al.
Publicat: (2002)

Dataset for proteomic analysis of arylamine N-acetyltransferase 1 knockout MDA-MB-231 breast cancer cells
per: Kyung U. Hong, et al.
Publicat: (2022-12-01)